Novo Nordisk Foundation Invests $600M in Quantum Chip Factory

The Novo Nordisk Foundation, owner of the pharmaceutical giant, is investing 600 million in a quantum chip manufacturing facility. This marks a significant diversification by a major healthcare-linked foundation into advanced technology, potentially boosting quantum computing supply chains. The move signals growing private investment in quantum hardware, though the specific technology and timeline remain unclear.